Show simple item record

dc.contributor.authorBurza, S*
dc.contributor.authorCroft, SL*
dc.contributor.authorBoelaert, M*
dc.date.accessioned2018-08-26T07:29:14Z
dc.date.available2018-08-26T07:29:14Z
dc.date.issued2018-08-17
dc.date.submitted2018-08-25
dc.identifier.citationLeishmaniasis. 2018 Lanceten
dc.identifier.issn1474-547X
dc.identifier.pmid30126638
dc.identifier.doi10.1016/S0140-6736(18)31204-2
dc.identifier.urihttp://hdl.handle.net/10144/619264
dc.description.abstractLeishmaniasis is a poverty-related disease with two main clinical forms: visceral leishmaniasis and cutaneous leishmaniasis. An estimated 0·7-1 million new cases of leishmaniasis per year are reported from nearly 100 endemic countries. The number of reported visceral leishmaniasis cases has decreased substantially in the past decade as a result of better access to diagnosis and treatment and more intense vector control within an elimination initiative in Asia, although natural cycles in transmission intensity might play a role. In east Africa however, the case numbers of this fatal disease continue to be sustained. Increased conflict in endemic areas of cutaneous leishmaniasis and forced displacement has resulted in a surge in these endemic areas as well as clinics across the world. WHO lists leishmaniasis as one of the neglected tropical diseases for which the development of new treatments is a priority. Major evidence gaps remain, and new tools are needed before leishmaniasis can be definitively controlled.
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to Lancet (London, England)en
dc.titleLeishmaniasisen
dc.identifier.journalLancet (London, England)en
refterms.dateFOA2019-03-04T14:08:52Z
html.description.abstractLeishmaniasis is a poverty-related disease with two main clinical forms: visceral leishmaniasis and cutaneous leishmaniasis. An estimated 0·7-1 million new cases of leishmaniasis per year are reported from nearly 100 endemic countries. The number of reported visceral leishmaniasis cases has decreased substantially in the past decade as a result of better access to diagnosis and treatment and more intense vector control within an elimination initiative in Asia, although natural cycles in transmission intensity might play a role. In east Africa however, the case numbers of this fatal disease continue to be sustained. Increased conflict in endemic areas of cutaneous leishmaniasis and forced displacement has resulted in a surge in these endemic areas as well as clinics across the world. WHO lists leishmaniasis as one of the neglected tropical diseases for which the development of new treatments is a priority. Major evidence gaps remain, and new tools are needed before leishmaniasis can be definitively controlled.


Files in this item

Thumbnail
Name:
Burza et al - 2018 - Leishmani ...
Size:
3.762Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record